Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Valvular Heart Disease

  Free Subscription


Articles published in Int J Cardiol

Retrieve available abstracts of 349 articles:
HTML format



Single Articles


    August 2026
  1. HUSSEIN H, Elsherif A, Mechery A, Lawton E, et al
    Temporal trends in causes, management and outcomes of cardiac tamponade complicating TAVI: A 12-year single-center experience.
    Int J Cardiol. 2026;456:134482.
    PubMed     Abstract available


    July 2026
  2. APOSTOLOS A, Konstantinou K, Allaf M, Sakalidis A, et al
    Self-expanding versus balloon-expandable valves in patients undergoing urgent or emergent TAVI.
    Int J Cardiol. 2026;454:134440.
    PubMed     Abstract available


    June 2026
  3. SPANJERSBERG TCF, Hassanzada F, Jongbloed JDH, Dooijes D, et al
    Population and family data support TNNT2 p.Arg288Cys as an intermediate effect variant in hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;452:134264.
    PubMed     Abstract available


    May 2026
  4. SEHOVIC S, Dilic M, Dzubur A, Hodzic E, et al
    A multimodal risk model integrating global longitudinal strain, BNP, and diastolic function for predicting remodeling and outcomes in severe asymptomatic aortic stenosis.
    Int J Cardiol. 2026 May 19:134562. doi: 10.1016/j.ijcard.2026.134562.
    PubMed     Abstract available


    April 2026
  5. CANO PR, Ruiz JMM, Sanchez IC, Gomez AG, et al
    Prognostic interaction of aortic regurgitation and left atrial strain beyond guideline-based intervention criteria.
    Int J Cardiol. 2026 Apr 28:134533. doi: 10.1016/j.ijcard.2026.134533.
    PubMed     Abstract available


  6. TOBE A, Smits PC, van Royen N, Amat-Santos IJ, et al
    Pacemaker recovery after permanent pacemaker implantation post-transcatheter aortic valve implantation: A sub-study of the LANDMARK trial.
    Int J Cardiol. 2026;456:134525.
    PubMed     Abstract available


  7. CHU SN, Zhang J, Yan ZC, Ren QW, et al
    Clinical outcomes of mild-to-moderate mixed aortic valve disease versus isolated aortic stenosis.
    Int J Cardiol. 2026 Apr 23:134497. doi: 10.1016/j.ijcard.2026.134497.
    PubMed     Abstract available


  8. OKITA S, Kitahara H, Kuji H, Miyakoda K, et al
    Prognostic impact of conduction disturbance subtypes after transcatheter aortic valve implantation.
    Int J Cardiol. 2026;455:134495.
    PubMed     Abstract available


  9. KAI T, Ajiro D, Yoshida T, Sekiguchi M, et al
    Comparative assessment of 4D CT-derived geometric and effective orifice areas in severe aortic stenosis.
    Int J Cardiol. 2026 Apr 2:134469. doi: 10.1016/j.ijcard.2026.134469.
    PubMed     Abstract available


  10. ZOCCHI C, Milazzo A, Panichella G, Garofalo M, et al
    Non-invasive evaluation of left ventricular hemodynamic force abnormalities in hypertrophic cardiomyopathy: Implications for myosin inhibition.
    Int J Cardiol. 2026;448:134175.
    PubMed     Abstract available


  11. BONACCHI G, Del Franco A, Agostoni P, Agricola E, et al
    Baseline clinical profile of patients with obstructive hypertrophic cardiomyopathy in the Italian Mavacamten early access program.
    Int J Cardiol. 2026;448:134152.
    PubMed     Abstract available


  12. LUPU L, Rogers T, Abusnina W, Haberman D, et al
    Coronary access after TAVR with the 4th and 5th -generation self-expanding Evolut valves: The EPROMPT-CA study.
    Int J Cardiol. 2026;448:134073.
    PubMed     Abstract available


    March 2026
  13. HSIAO CS, Hsiao SH, Shiau JW, Chiou KR, et al
    Prognostic impact of systolic pulmonary and aortic regurgitation in heart failure with preserved ejection fraction.
    Int J Cardiol. 2026;454:134436.
    PubMed     Abstract available


  14. EL-ANDARI R, Bozso SJ
    Sex differences after valve-in-valve transcatheter aortic valve implantation: The rule or the exception?
    Int J Cardiol. 2026 Mar 18:134433. doi: 10.1016/j.ijcard.2026.134433.
    PubMed    


  15. BJERREGAARD L, Maron MS, Jensen MSK, Dybro AM, et al
    Relationship between symptom assessment and cardiopulmonary exercise testing in patients with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;447:134147.
    PubMed     Abstract available


  16. MATTA MG, Dababneh E, Camuglia A, Niranjan S, et al
    Sex differences in patient-reported and clinical outcomes after valve-in-valve TAVI: Insights from the Australian ACOR registry.
    Int J Cardiol. 2026;453:134273.
    PubMed     Abstract available


    February 2026
  17. FISHMAN B, Maor E, Ashri S, Loutati R, et al
    The outcome of patients with severe tricuspid regurgitation by body mass index.
    Int J Cardiol. 2026;451:134251.
    PubMed     Abstract available


  18. FRUMKIN D, Nersesian G, Spethmann S, Hindricks G, et al
    Acute type A aortic dissection following TAVI.
    Int J Cardiol. 2026;445:134035.
    PubMed     Abstract available


  19. SISINNI A, Barreiro-Perez M, Freixa X, Arzamendi D, et al
    TRI.Fr eligibility criteria and outcome in real-world cohort of patients undergoing tricuspid transcatheter edge-to-edge repair.
    Int J Cardiol. 2026;445:134021.
    PubMed     Abstract available


  20. JIANG J, Sun L, Hong Q, Zhang J, et al
    Comprehensive assesment of right ventricular function in patients with primary mitral regurgitation.
    Int J Cardiol. 2026 Feb 10:134232. doi: 10.1016/j.ijcard.2026.134232.
    PubMed     Abstract available


  21. FREIXA-BENAVENTE A, Garrido-Oliver J, Roses-Noguer F, Dux-Santoy L, et al
    Blood speckle imaging for the assessment of aortic valve velocity in healthy children: Reproducibility and comparison with Doppler echocardiography.
    Int J Cardiol. 2026 Feb 4:134223. doi: 10.1016/j.ijcard.2026.134223.
    PubMed     Abstract available


  22. SHEASHAA H, Farina JM, Scalia IG, Awad K, et al
    Diagnostic performance of aortic valve calcium scoring for severe aortic stenosis in patients with chronic kidney disease.
    Int J Cardiol. 2026 Feb 3:134217. doi: 10.1016/j.ijcard.2026.134217.
    PubMed     Abstract available


  23. POLIZZI R, Canciello G, Ordine L, di Napoli S, et al
    Reverse septal curvature in hypertrophic cardiomyopathy: Implications for function, structure and arrhythmic risk.
    Int J Cardiol. 2026;444:134013.
    PubMed     Abstract available


  24. BONANNI F, Ballerini A, Gozzini A, Marchi A, et al
    Autosomal recessive hypertrophic cardiomyopathy associated with variants in TRIM63.
    Int J Cardiol. 2026;444:134010.
    PubMed     Abstract available


  25. SAKUL S, DiazSaravia S, Berman B, Dominguez AC, et al
    "Echo-derived estimate of peak left atrial pressure in patients with iatrogenic atrial septal defects following transcatheter mitral edge-to-edge repair".
    Int J Cardiol. 2026;444:133975.
    PubMed     Abstract available


    January 2026
  26. CANTONE A, Serenelli M, Porcari A
    Beyond the valve: The long shadow of transthyretin amyloidosis in aortic stenosis.
    Int J Cardiol. 2026;449:134196.
    PubMed    


  27. KHAN S, Balasubramanian A, Lim B, Demir O, et al
    PREDICT - patient referral evaluation to determine indication for computed tomography to identify small aortic annulus size in patients with severe aortic stenosis.
    Int J Cardiol. 2026 Jan 12:134177. doi: 10.1016/j.ijcard.2026.134177.
    PubMed     Abstract available


  28. PATEL KP, Autherith M, Scully PR, Koschutnik M, et al
    Long-term outcomes in patients with aortic stenosis and transthyretin cardiac amyloidosis.
    Int J Cardiol. 2026 Jan 8:134135. doi: 10.1016/j.ijcard.2025.134135.
    PubMed     Abstract available


  29. GAROFALO M, Scheggi V, Bohbot Y, Hasan J, et al
    Lower interventricular septal thickness from computed tomography predicts the need for pacemaker implantation after TAVR.
    Int J Cardiol. 2026;442:133915.
    PubMed     Abstract available


  30. TALMOR-BARKAN Y, Levi A, Barbanti M, Valvo R, et al
    The impact of contractile reserve on clinical outcomes in patients with left ventricular dysfunction undergoing TAVI.
    Int J Cardiol. 2026;442:133916.
    PubMed     Abstract available


  31. VESELKA J, Liebregts M, Cooper R, Faber L, et al
    Impact of centre experience on complete clinical and haemodynamic response after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2026;442:133865.
    PubMed     Abstract available


  32. NAGY V, Racz G, Takacs H, Boda K, et al
    Mavacamten effectively reduces > 100 mmHg left ventricular outflow tract gradients as early as one week of treatment in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2026;442:133882.
    PubMed     Abstract available


    December 2025
  33. KHEIFETS M, Levi A, Dvir GM, Belkin D, et al
    Transcatheter aortic valve replacement in patients with cancer: A 10-year registry analysis of early and long-term mortality outcomes.
    Int J Cardiol. 2025 Dec 31:134137. doi: 10.1016/j.ijcard.2025.134137.
    PubMed     Abstract available


  34. GOLDENBERG GR, Barsheshet A, Erez A, Tal S, et al
    Predictors and outcomes of high ventricular pacing burden post transcatheter aortic valve replacement: 5 years of follow-up.
    Int J Cardiol. 2025;447:134138.
    PubMed     Abstract available


  35. GRANOT YN, Bienstock SW, Karlsberg D, Tang GHL, et al
    Correcting CT-derived aortic valve area for LVOT ellipticity: A novel approach.
    Int J Cardiol. 2025 Dec 28:134122. doi: 10.1016/j.ijcard.2025.134122.
    PubMed     Abstract available


  36. OBI O, Ayesha A, Lajczak P, Hageen AW, et al
    Sutureless versus transcatheter aortic valve replacement in patients with aortic stenosis: An updated meta-analysis of short- and mid-term outcomes with trial sequential analysis.
    Int J Cardiol. 2025;447:134116.
    PubMed     Abstract available


  37. CORCIONE N, Giordano S, Ferraro P, Morello A, et al
    Percutaneous axillary vs femoral access for transcatheter aortic valve replacement: Insights from a 2164-patient study.
    Int J Cardiol. 2025;446:134093.
    PubMed     Abstract available


  38. HOROWITZ H, Amsalem I, Carasso S, Postell YY, et al
    Atrial fibrillation and clinical outcomes after mitral transcatheter edge-to-edge repair: A mechanism-stratified cohort study.
    Int J Cardiol. 2025;446:134095.
    PubMed     Abstract available


  39. HUA L, Pang S, Zhang Z, Chen J, et al
    Long-term outcomes of tricuspid valve plasty vs. replacement after cardiac surgery: Mortality, reoperation, and anticoagulation complications in patients with postoperative tricuspid regurgitation.
    Int J Cardiol. 2025;445:134080.
    PubMed     Abstract available


  40. ZUIN M, Balla C, Canovi L, Serenelli M, et al
    Tricuspid annular plane systolic excursion to systolic pulmonary artery pressure ratio in Hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;440:133680.
    PubMed     Abstract available


  41. ATIF MM, Lohano G, Ram M, Irshad NUN, et al
    Letter to the editor: Outcomes in patients undergoing trans-catheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025;440:133699.
    PubMed    


  42. PANG X, Zhao S, Zhang F
    Comment on: "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population".
    Int J Cardiol. 2025;440:133698.
    PubMed    


    November 2025
  43. AMIR R, Ladouceur M, Danford D, Aboulhosn J, et al
    Tricuspid valve surgery in transposition of the great arteries with a systemic right ventricle.
    Int J Cardiol. 2025 Nov 25:134055. doi: 10.1016/j.ijcard.2025.134055.
    PubMed     Abstract available


  44. CARRION-SANCHEZ I, Monteagudo-Ruiz JM, Ramos-Cano P, Martinez-Vives P, et al
    Prognostic significance of cardiovascular magnetic resonance advanced atrial parameters in chronic significant aortic regurgitation.
    Int J Cardiol. 2025;445:134028.
    PubMed     Abstract available


  45. SHATANOF R, Ghay S, Fernandez R, Elajami TK, et al
    Cardiac morphologic and functional characteristics in patients with left ventricular excessive Trabeculation versus apical hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;439:133650.
    PubMed     Abstract available


  46. MONASTYRSKI AV, Garcia VS, Carbajal RP, Munoz JM, et al
    Single perclose escalation technique: A novel approach for vascular closure following Transcatheter Aortic Valve Replacement.
    Int J Cardiol. 2025 Nov 11:134012. doi: 10.1016/j.ijcard.2025.134012.
    PubMed     Abstract available


  47. PAPAZOGLOU AS, Tsiartas E, Kyriakoulis KG, Moysidis DV, et al
    Prevalence and clinical impact of baseline atherosclerotic vascular disease in patients undergoing transcatheter aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025;444:134004.
    PubMed     Abstract available


    October 2025
  48. XIE P, Zhou H, Huang Y, Huang Z, et al
    Left ventricular diastolic function modifies clinical outcomes of mild mitral regurgitation.
    Int J Cardiol. 2025 Oct 31:133998. doi: 10.1016/j.ijcard.2025.133998.
    PubMed     Abstract available


  49. GONZALEZ-GOMEZ A, Monteagudo Ruiz JM, Arteagoitia Bolumburu A, Mahia P, et al
    The 4A classification for prognostic stratification of patients with tricuspid regurgitation. A multicenter study.
    Int J Cardiol. 2025;444:133977.
    PubMed     Abstract available


  50. SCHOONVELDE SAC, Nollet EE, Zwetsloot PP, Knackstedt C, et al
    Genotype-negative hypertrophic cardiomyopathy: Exploring the role of cardiovascular risk factors in disease expression.
    Int J Cardiol. 2025;437:133444.
    PubMed     Abstract available


  51. BATOOL SJ, Hasan M
    Comment on "Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification".
    Int J Cardiol. 2025 Oct 7:133966. doi: 10.1016/j.ijcard.2025.133966.
    PubMed    


  52. YANG L, Chen X, Fang Y, Chen D, et al
    Rate-adaptive pacing in right-sided heart failure with tricuspid regurgitation: A prospective pilot study.
    Int J Cardiol. 2025 Oct 6:133957. doi: 10.1016/j.ijcard.2025.133957.
    PubMed     Abstract available


  53. AVIEL G, Hirsh-Raccah B, Idais I, Ghannam RA, et al
    Worsening tricuspid regurgitation after mitral valve surgery: a meta-analysis and meta-regression.
    Int J Cardiol. 2025 Oct 4:133931. doi: 10.1016/j.ijcard.2025.133931.
    PubMed     Abstract available


  54. ZENG XM, Su Q, Mo LR
    Serum Alpha-1-microglobulin (A1M) and calcific aortic valve stenosis.
    Int J Cardiol. 2025 Oct 2:133953. doi: 10.1016/j.ijcard.2025.133953.
    PubMed    


  55. BURTON SM, Nelson M, Rigo G, Caputo M, et al
    Risk factors and clinical impact of transvalvular gradient following surgical repair of degenerative mitral regurgitation.
    Int J Cardiol. 2025 Oct 1:133929. doi: 10.1016/j.ijcard.2025.133929.
    PubMed     Abstract available


    September 2025
  56. HA ET, Phichaphop A, Case BC
    Concomitant coronary artery disease in those undergoing TAVR for severe aortic stenosis: A benign finding?
    Int J Cardiol. 2025 Sep 30:133948. doi: 10.1016/j.ijcard.2025.133948.
    PubMed    


  57. ALPERI A, Avanzas P
    SAPIEN 3 in type 0 bicuspid aortic valves: Promising early results.
    Int J Cardiol. 2025;443:133918.
    PubMed    


  58. KIRK BH, Palm P, Norgaard MW, Borregaard B, et al
    Prevention of readmission by intensified follow-up after transcatheter aortic valve implantation: Feasibility results of the PREMISS randomised controlled trial.
    Int J Cardiol. 2025 Sep 14:133894. doi: 10.1016/j.ijcard.2025.133894.
    PubMed     Abstract available


  59. ZAHID MH, Saleem M, Murtaza A
    Letter to the editor: Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Sep 6:133859. doi: 10.1016/j.ijcard.2025.133859.
    PubMed    


  60. LUNZE FI, Dusenbery SM, Gauvreau K, Lee JM, et al
    Mid-term ventricular function in patients with tetralogy of Fallot after transcatheter pulmonary valve replacement: Relationship to baseline right ventricular loading conditions.
    Int J Cardiol. 2025;434:133305.
    PubMed     Abstract available


    August 2025
  61. SHAWKI M, Sampaio Rodrigues T, Khabazi KP, Brick C, et al
    Short-term incidence and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy receiving cardiac myosin inhibitors: A systematic review and meta-analysis.
    Int J Cardiol. 2025;442:133846.
    PubMed     Abstract available


  62. DUAN YN
    Letter to the editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025 Aug 26:133829. doi: 10.1016/j.ijcard.2025.133829.
    PubMed    


  63. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to Letter to the Editor: Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Reinterpreting patient characteristics and institutional effects.
    Int J Cardiol. 2025 Aug 26:133830. doi: 10.1016/j.ijcard.2025.133830.
    PubMed    


  64. MARGONATO D, Morosato M, Ingallina G, Wang C, et al
    Natural history outcome of moderate tricuspid regurgitation with preserved left-ventricular ejection fraction.
    Int J Cardiol. 2025;442:133826.
    PubMed     Abstract available


  65. DONAL E, Rasmeehirun P, Petersen Saadi M
    From bottle to decanter: Revisiting eRVSP accuracy in the five-grade tricuspid regurgitation era.
    Int J Cardiol. 2025 Aug 20:133805. doi: 10.1016/j.ijcard.2025.133805.
    PubMed    


  66. MELILLO F, Speziale G
    Mitral valve treatment for mitral valve regurgitation: The past, the present and the future - A challenge for the surgeon and the imager.
    Int J Cardiol. 2025 Aug 19:133784. doi: 10.1016/j.ijcard.2025.133784.
    PubMed    


  67. SCHOPS LB, Fosbol EL, Ostergaard L
    Response to letter to editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 19:133808. doi: 10.1016/j.ijcard.2025.133808.
    PubMed    


  68. GITTO M, Kim WK, Buono A, Fabris T, et al
    Clinical outcomes in women and men with raphe-type bicuspid aortic valve stenosis undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2025;441:133792.
    PubMed     Abstract available


  69. FENG D, Wang M, Wang J, Liu X, et al
    Safety and efficacy of transcatheter aortic valve replacement using Sapien 3 balloon-expandable valve in type 0 bicuspid aortic valve stenosis patients.
    Int J Cardiol. 2025;441:133791.
    PubMed     Abstract available


  70. LATERRA G, Barbanti M, Rosato S, Biancari F, et al
    Incidence of cardiac ischemic events after transcatheter aortic valve replacement: Results from the OBSERVANT studies.
    Int J Cardiol. 2025 Aug 12:133779. doi: 10.1016/j.ijcard.2025.133779.
    PubMed     Abstract available


  71. ANNALISA P, Andrea P, Monica F, Giuseppe C, et al
    Genereux staging classification in predicting left ventricular reverse remodeling after intervention for severe aortic valve regurgitation.
    Int J Cardiol. 2025 Aug 12:133770. doi: 10.1016/j.ijcard.2025.133770.
    PubMed     Abstract available


  72. TARTAGLIA F, Gitto M, Villaschi A, Calamita G, et al
    Transcatheter therapies for tricuspid regurgitation: A meta-analysis of randomized trials.
    Int J Cardiol. 2025 Aug 11:133777. doi: 10.1016/j.ijcard.2025.133777.
    PubMed     Abstract available


  73. YANG T, Wang Y, Zhu G, Liu W, et al
    TRI-PLAN: A deep learning-based automated assessment framework for right heart assessment in transcatheter tricuspid valve replacement planning.
    Int J Cardiol. 2025 Aug 6:133732. doi: 10.1016/j.ijcard.2025.133732.
    PubMed     Abstract available


  74. YU C
    Letter to the editor: Concerns on methodology and interpretation in Schops' study on mitral valve surgery trends.
    Int J Cardiol. 2025 Aug 6:133723. doi: 10.1016/j.ijcard.2025.133723.
    PubMed    


  75. MEI Z, Guo C, Yang H, Li J, et al
    Serum Alpha-1-microglobulin (A1M) as an independent predictor of calcific aortic valve stenosis and its diagnostic value.
    Int J Cardiol. 2025;440:133706.
    PubMed     Abstract available


  76. ARSHAD A, Melin M, Lund LH, Manouras A, et al
    Assessing the accuracy of echocardiographic estimation of pulmonary pressures: Insights from a 5-grade tricuspid regurgitation classification.
    Int J Cardiol. 2025;440:133729.
    PubMed     Abstract available


  77. WANG B
    Letter to the Editor: Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Aug 4:133701. doi: 10.1016/j.ijcard.2025.133701.
    PubMed    


  78. SHI W, Wang M, Niu G, Zhao Z, et al
    Management of TAVR in asymptomatic or minimally symptomatic patients: Insights from resting angiographic microvascular resistance.
    Int J Cardiol. 2025;432:133263.
    PubMed     Abstract available


  79. AAMIR M, Bilquees A, Saleem D
    Addressing confounding factors in TEER outcomes: A call for deeper analysis [Re: Meulengracht et al., International Journal of Cardiology 439 (2025) 133605 - "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared t
    Int J Cardiol. 2025 Aug 1:133702. doi: 10.1016/j.ijcard.2025.133702.
    PubMed    


    July 2025
  80. GHAFFAR MD, Khan MA
    Refining patient selection and outcome assessment in transcatheter edge-to-edge mitral valve repair: Reflections on a Nationwide Danish study.
    Int J Cardiol. 2025;440:133679.
    PubMed    


  81. PAGNESI M, Adamo M
    Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025;439:133611.
    PubMed    


  82. MEULENGRACHT DE, Petersen JK, Veien KT, de Backer O, et al
    Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Jul 7:133605. doi: 10.1016/j.ijcard.2025.133605.
    PubMed     Abstract available


  83. ROGERS LJ, Dong T, Kota R, Chan J, et al
    Reoperative mitral valve surgery in the UK: 20-year trends and early outcomes.
    Int J Cardiol. 2025 Jul 5:133602. doi: 10.1016/j.ijcard.2025.133602.
    PubMed     Abstract available


  84. XU Z, Chen L, Dai X, Lin Z, et al
    Midterm outcomes of thoracoscopic trans-mitral myectomy for hypertrophic obstructive cardiomyopathy: A single-center, observational study.
    Int J Cardiol. 2025;430:133216.
    PubMed     Abstract available


    June 2025
  85. CELEGHIN R, Pilichou K
    Mitral valve prolapse: A clinical puzzle in search of molecular solutions.
    Int J Cardiol. 2025 Jun 30:133563. doi: 10.1016/j.ijcard.2025.133563.
    PubMed    


  86. REN CB, van den Dorpel MMP, Geleijnse M, van Mieghem NM, et al
    How accurate is intraprocedural transthoracic echocardiography in assessing aortic regurgitation after transcathether aortic valve implantation? A single center experience.
    Int J Cardiol. 2025;438:133565.
    PubMed     Abstract available


  87. SONG Y, Ma F, Bao X, Liu Y, et al
    Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
    PubMed    


  88. BARILI F, Pollari F, Marin-Cuartas M, Anselmi A, et al
    Time-to-event analysis of the long-term outcome in trials comparing transcatheter and surgical aortic valve implantation: A meta-analysis.
    Int J Cardiol. 2025 Jun 24:133524. doi: 10.1016/j.ijcard.2025.133524.
    PubMed     Abstract available


  89. SCHOPS LB, Truong S, Petersen J, Alhakak A, et al
    Trends in mitral valve surgery for mitral valve regurgitation in Denmark: Changes in patient characteristics and mortality from 1996 to 2022.
    Int J Cardiol. 2025;438:133552.
    PubMed     Abstract available


  90. SCHREURS BA, van Kimmenade RRJ, Eijsvogels TMH
    Reply by Schreurs et al. to letter regarding article: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025 Jun 20:133545. doi: 10.1016/j.ijcard.2025.133545.
    PubMed    


  91. IMRAN A, Haider A
    Comment on "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study".
    Int J Cardiol. 2025;438:133534.
    PubMed    


  92. AWAD DM
    Bridging the Gap: Addressing the Underuse of Transcatheter Edge-to-Edge Repair in Chinese Patients with Significant Mitral Regurgitation.
    Int J Cardiol. 2025;438:133519.
    PubMed    


  93. VESELKA J, Hansvenclova E, Tesarkova KH, Januska J, et al
    Comparable outcomes in single versus multiple septal branches alcohol ablation for obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;429:133145.
    PubMed     Abstract available


  94. LORENZATTI A
    Cholesterol and Valvular heart disease: Is Lipoprotein(a) the sole culprit?
    Int J Cardiol. 2025;437:133510.
    PubMed    


  95. TREMAMUNNO G, De Santis D, Santangeli C, Bona GG, et al
    Comparative analysis of pre-transcatheter aortic valve implantation CTA protocols: Optimizing radiation dose and contrast volume.
    Int J Cardiol. 2025;437:133514.
    PubMed     Abstract available


  96. JARRAR Y, Alomari L, Otabor E, Lam J, et al
    A safer bet for MitraClip: Choosing between single antiplatelet therapy and dual antiplatelet therapy.
    Int J Cardiol. 2025;437:133476.
    PubMed     Abstract available


    May 2025
  97. LORETZ L, Kim WK, de Backer O, Brunner S, et al
    PVL in ACURATE neo2 self-expanding aortic valve prosthesis for transcatheter aortic valve replacement - A multicenter retrospective registry analysis.
    Int J Cardiol. 2025;436:133428.
    PubMed     Abstract available


  98. TRUONG S, Fosbol E, Ostergaard L
    Reply to "Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective".
    Int J Cardiol. 2025 May 27:133431. doi: 10.1016/j.ijcard.2025.133431.
    PubMed    


  99. NONAKA H, Asami M, Horiuchi Y, Tanaka J, et al
    Validation of MitraScore in diverse mitral regurgitation subtypes: Insights from the OCEAN-mitral registry.
    Int J Cardiol. 2025 May 27:133427. doi: 10.1016/j.ijcard.2025.133427.
    PubMed     Abstract available


  100. EBRAHIMI S
    Early aortic valve replacement in asymptomatic severe aortic stenosis: A turning point in management.
    Int J Cardiol. 2025;435:133411.
    PubMed    


  101. BLACKMAN DJ, Aktaa S, Pickles D, Abdel-Wahab M, et al
    REdo transcatheter aortic VALVE implantation for the management of transcatheter aortic valve failure: Design and rationale of the REVALVE study.
    Int J Cardiol. 2025 May 18:133400. doi: 10.1016/j.ijcard.2025.133400.
    PubMed     Abstract available


  102. HASSAN SAU, Huda NU, Maheen M
    Letter to the editor: Physical activity characteristics in adults with bicuspid aortic valve versus age and sex matched controls.
    Int J Cardiol. 2025;435:133392.
    PubMed    


  103. JABRI A, Suri RM, Villablanca P
    Redo or Redon't? Mitral valve reoperation vs. first-time surgery outcomes: A nationwide study.
    Int J Cardiol. 2025;434:133353.
    PubMed    


  104. FATH AR, Aglan A, Maron MS, Phillips JS, et al
    Cardiovascular outcomes of glucagon-like peptide-1 agonist in patients with obesity and hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;426:133082.
    PubMed     Abstract available


    April 2025
  105. CHEN B, Wang C, Li W
    Comprehensive genetic analysis based on multi - omics reveals novel therapeutic targets for mitral valve prolapse and drug molecular dynamics simulation.
    Int J Cardiol. 2025 Apr 29:133325. doi: 10.1016/j.ijcard.2025.133325.
    PubMed     Abstract available


  106. SCHREURS BA, van der Sluijs KM, Hopman MTE, Bakker EA, et al
    Physical activity characteristics in adults with bicuspid aortic valve versus age- and sex-matched controls.
    Int J Cardiol. 2025 Apr 29:133330. doi: 10.1016/j.ijcard.2025.133330.
    PubMed     Abstract available


  107. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    Reply to: Correction to external evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2025;433:133310.
    PubMed    


  108. WEI P, Zhao G, Dong J, Feng S, et al
    Anatomical suitability and clinical outcomes of transcatheter edge-to-edge repair in Chinese patients with significant mitral regurgitation: A real-world echocardiographic study.
    Int J Cardiol. 2025;433:133317.
    PubMed     Abstract available


  109. MAYNTZ SP, Davidovski FS
    Improving gender-specific management of aortic stenosis with IMPULSE registry data.
    Int J Cardiol. 2025;433:133293.
    PubMed    


  110. SITGES M
    Improving our management of tricuspid regurgitation: present and future opportunities.
    Int J Cardiol. 2025 Apr 18:133288. doi: 10.1016/j.ijcard.2025.133288.
    PubMed    


  111. MCDONOUGH RV
    Correction to: External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard (Int J Cardiol. 2025;419:132653).
    Int J Cardiol. 2025;432:133260.
    PubMed    


  112. JACQUEMYN X, Sa MP, Marin-Cuartas M, Bax JJ, et al
    Early aortic valve replacement versus conservative management in asymptomatic severe aortic stenosis: Meta-analysis of time-to-event data of randomized controlled trials.
    Int J Cardiol. 2025;432:133269.
    PubMed     Abstract available


  113. IFTIKHAR MK, Iftikhar QUA, Baig MMA
    Mitral valve reoperation: Refining risk stratification for better outcomes.
    Int J Cardiol. 2025;431:133239.
    PubMed    


  114. JAVED MN, Ahmed U, Eman NU
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A critical perspective.
    Int J Cardiol. 2025;431:133238.
    PubMed    


    March 2025
  115. BLEIZIFFER S, Messika-Zeitoun D, Steeds R, Appleby C, et al
    Gender differences in the presentation and management of patients with severe aortic stenosis at specialist versus primary/sondary care centres: A sub-analysis of the IMPULSE enhanced registry.
    Int J Cardiol. 2025 Mar 30:133223. doi: 10.1016/j.ijcard.2025.133223.
    PubMed     Abstract available


  116. LUO D, Bjornson E, Wang X, Zhang B, et al
    Distinct lipoprotein contributions to valvular heart disease: Insights from genetic analysis.
    Int J Cardiol. 2025 Mar 27:133218. doi: 10.1016/j.ijcard.2025.133218.
    PubMed     Abstract available


  117. TRUONG S, Petersen J, Havers-Borgersen E, Schops LB, et al
    Outcomes of mitral valve reoperation and first-time surgery for mitral regurgitation: A nationwide study.
    Int J Cardiol. 2025 Mar 18:133175. doi: 10.1016/j.ijcard.2025.133175.
    PubMed     Abstract available


  118. CAI Y, Ou M, Li Y, Zhang X, et al
    Parameters of speckle tracking echocardiography in right atrial fibrosis of patients with rheumatic mitral stenosis: Focusing on right atrial stiffness.
    Int J Cardiol. 2025;429:133170.
    PubMed     Abstract available


  119. LAI Q, Wei Z, Zhang X, Li Q, et al
    The passability of delivery catheter system during self-expanding transcatheter aortic valve replacement: A CT-based prediction model.
    Int J Cardiol. 2025 Mar 16:133168. doi: 10.1016/j.ijcard.2025.133168.
    PubMed     Abstract available


  120. GODINO C, Nemola G, Sisinni A, Margonato D, et al
    Therapeutical approach of tricuspid regurgitation and right heart failure.
    Int J Cardiol. 2025;429:133163.
    PubMed     Abstract available


  121. SONAGLIONI A, Nicolosi GL, Lombardo M
    Navigating the prognostic risk stratification of moderate and severe asymptomatic aortic stenosis.
    Int J Cardiol. 2025;429:133141.
    PubMed    


  122. AHMED A, Safiriyu I, Kaddoura R, Mohyeldin M, et al
    Outcomes of transcatheter aortic valve implantation in Africa: A systematic review and meta-analysis.
    Int J Cardiol. 2025 Mar 10:133139. doi: 10.1016/j.ijcard.2025.133139.
    PubMed     Abstract available


  123. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
    Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
    PubMed     Abstract available


  124. TAKAHARI K, Utsunomiya H, Tohgi K, Hamada A, et al
    Tissue-tracking mitral annular displacement predicts impaired left ventricular mechanics and adverse outcomes in aortic stenosis with preserved left ventricular ejection fraction.
    Int J Cardiol. 2025 Mar 2:133106. doi: 10.1016/j.ijcard.2025.133106.
    PubMed     Abstract available


  125. FERRI LA, Ancona MB, Papageorgiou C, Vella C, et al
    Computed tomography derived predictors of left ventricular obstruction after TAVR.
    Int J Cardiol. 2025;422:132956.
    PubMed     Abstract available


  126. KHAN S, Demir O, Mehmood M, Nabi I, et al
    An automated method of streamlining waiting list by clinical risk fast-tracking for patients awaiting TAVR: SWIFT TAVR algorithm.
    Int J Cardiol. 2025;422:132952.
    PubMed     Abstract available


  127. SCHOONVELDE SAC, Alexandridis GM, Price LB, Schinkel AFL, et al
    Family screening for hypertrophic cardiomyopathy: Initial cardiologic assessment, and long-term follow-up of genotype-positive phenotype-negative individuals.
    Int J Cardiol. 2025;422:132951.
    PubMed     Abstract available


    February 2025
  128. AKITA K, Suwa K, Ohno K, Weiner SD, et al
    Detection of late gadolinium enhancement in patients with hypertrophic cardiomyopathy using machine learning.
    Int J Cardiol. 2025;421:132911.
    PubMed     Abstract available


  129. GULER A, Erata YE, Demirtola AI, Turkmen I, et al
    The effect of disopyramide therapy on functional capacity improvement in patients with obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2025;421:132913.
    PubMed     Abstract available


  130. ZENG X, Wu H, Wang R, Huang P, et al
    Major adverse cardiovascular events after modified morrow surgery in hypertrophic obstructive cardiomyopathy: A 12-year cohort study.
    Int J Cardiol. 2025;421:132864.
    PubMed     Abstract available


  131. ABBAS MT, Farina JM, Awad K, Badr A, et al
    The association of bisphosphonates, calcium levels and PTH levels with bioprosthetic aortic valve degeneration.
    Int J Cardiol. 2025;425:133067.
    PubMed     Abstract available


  132. KOLIASTASIS L, Kim WK
    Coronary physiology assessment in severe aortic stenosis: Feasible yet challenging.
    Int J Cardiol. 2025 Feb 13:133063. doi: 10.1016/j.ijcard.2025.133063.
    PubMed    


    January 2025
  133. ALNABTI A, Abujalala S, Al-Hijji M, Othman K, et al
    Outcomes of the Transcatheter aortic valve implantation- registry (QATAVI-registry) -first report 24/7/2024.
    Int J Cardiol. 2025 Jan 29:133029. doi: 10.1016/j.ijcard.2025.133029.
    PubMed     Abstract available


  134. TUSA M, Amicone S
    Rediscovering racial disparities in tricuspid regurgitation: A call for increased and targeted treatment approach.
    Int J Cardiol. 2025 Jan 25:133007. doi: 10.1016/j.ijcard.2025.133007.
    PubMed    


  135. LU T, Zhu C, Cui H, Meng Y, et al
    Preoperative D-dimer and outcomes in obstructive hypertrophic cardiomyopathy after myectomy.
    Int J Cardiol. 2025;419:132705.
    PubMed     Abstract available


  136. JENSEN RV, Jensen JM, Iraqi N, Grove EL, et al
    Coronary CT angiography instead of invasive angiography before TAVI: Feasibility and outcomes.
    Int J Cardiol. 2025;419:132694.
    PubMed     Abstract available


  137. ZHANG L, Ding F, Ren Z, Cheng W, et al
    Mechanisms of pathogenicity in the hypertrophic cardiomyopathy-associated TNNI3 c.235C > T variant.
    Int J Cardiol. 2025;419:132627.
    PubMed     Abstract available


  138. KIM M, Seo J, Kim IS, Cho S, et al
    Differential determinants and prognostic value of aortic valve sclerosis over carotid atherosclerosis.
    Int J Cardiol. 2025 Jan 11:132980. doi: 10.1016/j.ijcard.2025.132980.
    PubMed     Abstract available


  139. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
    Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
    Int J Cardiol. 2025;422:132958.
    PubMed     Abstract available


    December 2024
  140. GAMARRA-VALVERDE NN, Masket D, Henry ML, Mares AC, et al
    Anticoagulation therapy for the prevention of subclinical leaflet thrombosis after transcatheter aortic valve replacement: A comprehensive literature review and future directions.
    Int J Cardiol. 2024 Dec 28:132946. doi: 10.1016/j.ijcard.2024.132946.
    PubMed     Abstract available


  141. ALBULUSHI A, Al-Abri U, Al Matrooshi N, Alsabti H, et al
    Pulmonary hypertension as a prognostic marker in low-flow low-gradient aortic stenosis: Insights from invasive hemodynamics and post-TAVR outcomes.
    Int J Cardiol. 2024;421:132910.
    PubMed     Abstract available


  142. MUSHTAQ S, Chiesa M, Novelli V, Sommariva E, et al
    Role of advanced CMR features in identifying a positive genotype of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132554.
    PubMed     Abstract available


  143. HAGEGE A, Puscas T, El Hachmi M, Parodi A, et al
    The French hypertrophic cardiomyopathy gene register: A systematic large gene screening for hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;417:132542.
    PubMed     Abstract available


  144. CORCIONE N, Ferraro P, Finizio F, Cimmino M, et al
    Overall impact of tethering and of its symmetric and asymmetric subtypes on early and long-term outcome of transcatheter edge-to-edge repair of significant mitral valve regurgitation.
    Int J Cardiol. 2024;421:132874.
    PubMed     Abstract available


  145. CESMAT AP, Chaudry AM, Gupta S, Weickert TT, et al
    Left ventricular hypertrophy and ventricular ectopy in mitral valve prolapse.
    Int J Cardiol. 2024;421:132888.
    PubMed     Abstract available


  146. ECHARTE-MORALES J, Scotti A, Bonnet G, Torrado J, et al
    Racial and ethnic disparities in patients with severe tricuspid regurgitation: The Bronx-Valve registry.
    Int J Cardiol. 2024;421:132889.
    PubMed     Abstract available


  147. SAIJO Y, Okushi Y, Gillinov AM, Pettersson GB, et al
    Sex-related differences in outcomes and prognosis of severe calcific mitral stenosis due to mitral annular calcification: A propensity-score matched cohort study.
    Int J Cardiol. 2024;421:132893.
    PubMed     Abstract available


  148. KIM WK, Bleiziffer S
    Are there sex-specific disparities in transcatheter aortic valve implantation?
    Int J Cardiol. 2024;421:132882.
    PubMed    


  149. PANG S, Wu J, Ke Y, Wang Q, et al
    Letter to the Editor: Insight into functional tricuspid valve regurgitation pathogenesis, pathological stages, and surgical management.
    Int J Cardiol. 2024;421:132883.
    PubMed    


  150. YAN T, Weng F, Guo C
    miR-124-3p may exert its effects in hypertrophic cardiomyopathy by inhibiting cardiomyocyte apoptosis.
    Int J Cardiol. 2024;416:132470.
    PubMed    


    November 2024
  151. FEZZI S, Pesarini G, Flaim M, Ding D, et al
    Influence of physiological patterns of coronary disease on fractional flow reserve and instantaneous wave-free ratio changes in patients undergoing TAVI.
    Int J Cardiol. 2024 Nov 25:132761. doi: 10.1016/j.ijcard.2024.132761.
    PubMed     Abstract available


  152. HAFIANE A, Pisaturo A, Favari E, Bortnick AE, et al
    Atherosclerosis, calcific aortic valve disease and mitral annular calcification: Same or different?
    Int J Cardiol. 2024 Nov 16:132741. doi: 10.1016/j.ijcard.2024.132741.
    PubMed     Abstract available


  153. BERGHMANS S, Eyskens B, Rega F, Moons P, et al
    A retrospective study: Long term prognosis in adults with PA-VSD-MAPCAs.
    Int J Cardiol. 2024;415:132476.
    PubMed     Abstract available


  154. SANNA GD, Finocchiaro G
    Sarcomere gene mutations in hypertrophic cardiomyopathy: how to clinically manage this information?
    Int J Cardiol. 2024;415:132373.
    PubMed    


  155. BONAVENTURA J, Maron BJ
    Chasing the molecular background of hypertrophic cardiomyopathy: The continuing saga to predict adverse outcomes with sarcomere mutations.
    Int J Cardiol. 2024;415:132366.
    PubMed    


  156. PEREIRA AR, Al Jaff AAM, Cabezas JM, de Weger A, et al
    Unilateral-access vs. bilateral-access in transfemoral transcatheter aortic valve replacement: A slim fit approach.
    Int J Cardiol. 2024 Nov 14:132712. doi: 10.1016/j.ijcard.2024.132712.
    PubMed     Abstract available


  157. ABRAHAM B, Sous M, Kaldas S, Nakhla M, et al
    Transcaval access for transcatheter aortic valve implantation: A meta-analysis and systematic review.
    Int J Cardiol. 2024 Nov 11:132720. doi: 10.1016/j.ijcard.2024.132720.
    PubMed     Abstract available


  158. LIN S, Zhang Y, Wang S, Ding X, et al
    Prognostic utility of dynamic changes in epicardial adipose tissue in patients undergoing transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Nov 10:132697. doi: 10.1016/j.ijcard.2024.132697.
    PubMed     Abstract available


  159. EL MATHARI S, Hopman LHGA, Bouchnaf C, Heidendael JF, et al
    Clinical implications of different methods to assess left atrial remodeling: A comparative study between echocardiography and cardiac magnetic resonance imaging for left atrial volume index quantification.
    Int J Cardiol. 2024;414:132443.
    PubMed     Abstract available


  160. FERNANDEZ A, Niel N, Parma G, Loza G, et al
    Warfarin use is associated with higher aortic bioprosthetic 18F-fluoride PET uptake.
    Int J Cardiol. 2024;414:132394.
    PubMed     Abstract available


    October 2024
  161. YANG Y, Ye Y
    Women: More susceptible to develop unfavorable in-hospital outcomes after transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Oct 22:132678. doi: 10.1016/j.ijcard.2024.132678.
    PubMed    


  162. ALPERI A, Avanzas P
    TAVR in tapered raphe-type stenotic bicuspid aortic valves: excellent results in challenging anatomies.
    Int J Cardiol. 2024 Oct 19:132656. doi: 10.1016/j.ijcard.2024.132656.
    PubMed    


  163. ROQUEMEN-ECHEVERRI V, Jacobs PG, Shalen EF, Schulman PM, et al
    External evaluation of a commercial artificial intelligence-augmented digital auscultation platform in valvular heart disease detection using echocardiography as reference standard.
    Int J Cardiol. 2024 Oct 19:132653. doi: 10.1016/j.ijcard.2024.132653.
    PubMed     Abstract available


  164. FIGLIOZZI S, Masci PG, Monti L, Stankowski K, et al
    Prognostic value of right ventricular involvement in hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2024;413:132390.
    PubMed     Abstract available


  165. KUMAR M, Hu JR, Ali S, Khlidj Y, et al
    Sex disparities in outcomes of transcatheter aortic valve implantation- a multi-year propensity-matched nationwide study.
    Int J Cardiol. 2024;418:132619.
    PubMed     Abstract available


  166. TRUONG S, Petersen J, Schmiegelow MDS, Due H, et al
    Incidence and factors associated with mitral valve reoperation in patients undergoing surgery for mitral regurgitation: A nationwide cohort study.
    Int J Cardiol. 2024;418:132608.
    PubMed     Abstract available


    September 2024
  167. SAITO T, Tsuruta H, Iwata J, Kajino A, et al
    Impact of beta-blocker uptitration on patients after transcatheter edge-to-edge mitral valve repair for secondary mitral regurgitation: The OCEAN-mitral registry.
    Int J Cardiol. 2024 Sep 24:132595. doi: 10.1016/j.ijcard.2024.132595.
    PubMed     Abstract available


  168. BUONO A, De Biase C, Fabris T, Bellamoli M, et al
    CharActeristics, sizing anD outcomes of stenotic, tapered, rapHe-type bicuspid aOrtic valves treated with trans-catheter device implantation: Insights the AD HOC registry.
    Int J Cardiol. 2024 Sep 18:132569. doi: 10.1016/j.ijcard.2024.132569.
    PubMed     Abstract available


  169. HARIKRISHNAN S, Koshy L, Ganapathi S, Jeemon P, et al
    Clinical exome sequencing unravels the diverse spectrum of genetic heterogeneity and genotype-phenotype correlations in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;411:132273.
    PubMed     Abstract available


  170. BANSAL S, Gupta A
    TAVR outcomes in females - What is changing!
    Int J Cardiol. 2024;411:132247.
    PubMed    


  171. ABU-MUCH A, Grines CL, Chen S, Batchelor WB, et al
    Clinical outcomes among patients with mitral valve regurgitation undergoing Impella-supported high-risk PCI.
    Int J Cardiol. 2024;417:132555.
    PubMed     Abstract available


  172. PISKLOVA M, Osmak G
    Unveiling MiRNA-124 as a biomarker in hypertrophic cardiomyopathy: An innovative approach using machine learning and intelligent data analysis.
    Int J Cardiol. 2024;410:132220.
    PubMed     Abstract available


  173. GOMEZ-HERRERO J, Fernandez-Cordon C, Gonzalez JC, Garcia-Gomez M, et al
    TAV-in-TAV in patients with prosthesis embolization: Impact of commissural alignment and global outcomes.
    Int J Cardiol. 2024;410:132179.
    PubMed     Abstract available


    August 2024
  174. MARGONATO D
    The therapeutical role of balloon aortic valvuloplasty: Back to the origin?
    Int J Cardiol. 2024 Aug 28:132493. doi: 10.1016/j.ijcard.2024.132493.
    PubMed    


  175. BONFIOLI GB, Pagnesi M
    Pulmonary vein flow pattern: A marker of successful repair in primary mitral regurgitation?
    Int J Cardiol. 2024 Aug 28:132498. doi: 10.1016/j.ijcard.2024.132498.
    PubMed    


  176. LAI KY, Lee CY, Chang YC, Liu K, et al
    Prognostic value of fully-automated left atrial strain in patients with asymptomatic chronic severe aortic regurgitation.
    Int J Cardiol. 2024 Aug 27:132487. doi: 10.1016/j.ijcard.2024.132487.
    PubMed     Abstract available


  177. LIU T, Yang X, Jia R, Han J, et al
    Left atrial mechanical dispersion and left atrial stiffness predicts recurrence of atrial fibrillation: In patients with moderate-severe rheumatic mitral stenosis.
    Int J Cardiol. 2024 Aug 26:132480. doi: 10.1016/j.ijcard.2024.132480.
    PubMed     Abstract available


  178. HUANG Z, Lin K, Huang J, Chen Y, et al
    Characteristics and outcomes associated with sarcomere mutations in patients with hypertrophic cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2024;409:132213.
    PubMed     Abstract available


  179. FAN J, Li Z, Lin D, Miao J, et al
    Long-term outcomes in patients with bicuspid valve stenosis and aortic dilation undergoing transcatheter valve implantation.
    Int J Cardiol. 2024;409:132201.
    PubMed     Abstract available


  180. FAGGI A, Denti P
    Contemporary TAVI counterindications and space for staged procedures.
    Int J Cardiol. 2024;409:132172.
    PubMed    


  181. NASIR MM, Amir S, Shahid A, Rehman WU, et al
    Valve-in-valve transcatheter mitral valve replacement versus redo-surgical mitral valve replacement for degenerated bioprosthetic mitral valves: A systematic review and meta-analysis.
    Int J Cardiol. 2024;415:132448.
    PubMed     Abstract available


  182. AMSALEM I, Carasso S
    Increased utilization of mitral transcatheter edge-to-edge repair in degenerative mitral regurgitation: The essential need for better prognostic and procedural success tools.
    Int J Cardiol. 2024 Aug 14:132457. doi: 10.1016/j.ijcard.2024.132457.
    PubMed    


  183. GE Z, Ge Z, Hu C, Wang Y, et al
    Characteristic of myocardial work in mitral valve prolapse with versus without mitral annular disjunction: A propensity-matched study.
    Int J Cardiol. 2024 Aug 6:132434. doi: 10.1016/j.ijcard.2024.132434.
    PubMed     Abstract available


  184. YEDIDYA I, Stassen J, Butcher S, van Wijngaarden AL, et al
    The prognostic value of changes in pulmonary vein flow patterns after surgical repair for primary mitral regurgitation.
    Int J Cardiol. 2024;414:132414.
    PubMed     Abstract available


  185. YAGI N, Hasegawa H, Kuwajima K, Ogawa M, et al
    Indexed aortic valve area using multimodality imaging for assessing the severity of bicuspid aortic stenosis.
    Int J Cardiol. 2024;414:132416.
    PubMed     Abstract available


  186. SPRINGHETTI P, Tomaselli M, Clavel MA
    Measuring the aortic valvular area: Key challenges in aortic stenosis assessment.
    Int J Cardiol. 2024;414:132410.
    PubMed    


  187. LORCA R, Salgado M, Alvarez-Velasco R, Reguro JR, et al
    Survival analysis and gender differences in hypertrophic cardiomyopathy proband patients referred for genetic testing.
    Int J Cardiol. 2024;408:132117.
    PubMed     Abstract available


  188. TONDI L, Pica S, Crimi G, Disabato G, et al
    "Interstitial fibrosis is associated with left atrial remodeling and adverse clinical outcomes in selected low-risk patients with hypertrophic cardiomyopathy".
    Int J Cardiol. 2024;408:132135.
    PubMed     Abstract available


  189. BESOLA L, Falcetta G, Ceravolo G, Fiocco A, et al
    New echocardiographic screening tool for left ventricular tract obstruction risk assessment in TMVR.
    Int J Cardiol. 2024;408:132112.
    PubMed     Abstract available


    July 2024
  190. HUSSAIN B, Tarabanis C, Aslam MMS, Dhulipala V, et al
    Inpatient outcomes of mechanical circulatory support devices and heart transplantation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;413:132396.
    PubMed     Abstract available


  191. RAHOUMA M, Khairallah S, Lau C, Al Zghari T, et al
    The impact of comorbidities on outcomes of concomitant mitral valve intervention with ascending aortic surgery.
    Int J Cardiol. 2024;413:132398.
    PubMed     Abstract available


  192. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
    Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
    Int J Cardiol. 2024;413:132399.
    PubMed     Abstract available


  193. TOMSIC A, Holubec T, Sandoval E, Pham T, et al
    Mitral valve repair with resection and non-resection techniques in Barlow's disease: A multi-center study.
    Int J Cardiol. 2024 Jul 22:132387. doi: 10.1016/j.ijcard.2024.132387.
    PubMed     Abstract available


  194. DE FELICE F, Musto C, Paolucci L
    TAVR in bicuspid aortic valve and ascending aorta dilatation: sitting on a fence or jumping on the bandwagon.
    Int J Cardiol. 2024 Jul 19:132372. doi: 10.1016/j.ijcard.2024.132372.
    PubMed    


  195. AMADOR AF
    Edmonton frail scale in TAVI patients: A new tool for frailty assessment and outcomes prediction.
    Int J Cardiol. 2024;407:132024.
    PubMed    


  196. DAYAN V, Fernandez A, Loza G, Parma G, et al
    Early anticoagulation after aortic valve replacement with porcine bioprosthesis randomized control trial(ANTIPRO). 3?years follow-up.
    Int J Cardiol. 2024 Jul 12:132361. doi: 10.1016/j.ijcard.2024.132361.
    PubMed     Abstract available


  197. ALBANI S, Merlo M
    Left ventricle late gadolinium enhancement and risk of atrial fibrillation in patients with hypertrophic cardiomyopathy: Another brick towards a precise approach.
    Int J Cardiol. 2024;413:132357.
    PubMed    


  198. LOFFI M, Adamo M, Rubbio AP, Pezzola E, et al
    Prevalence and outcome of elderly and low-risk patients with degenerative mitral regurgitation undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jul 8:132317. doi: 10.1016/j.ijcard.2024.132317.
    PubMed     Abstract available


  199. FUJIMOTO T, Zen K, Kataoka E, Kitada T, et al
    Balloon aortic valvuloplasty bridge to transcatheter aortic valve replacement is associated with worse in-hospital mortality.
    Int J Cardiol. 2024 Jul 6:132348. doi: 10.1016/j.ijcard.2024.132348.
    PubMed     Abstract available


  200. OMAR P, Giovanni B, Williams J, Thomas F, et al
    Quantification of anatomical aortic valve area by multi-detector computed tomography: A pilot 3D-morphological modeling of the stenotic aortic valve.
    Int J Cardiol. 2024 Jul 6:132322. doi: 10.1016/j.ijcard.2024.132322.
    PubMed     Abstract available


  201. HEEGER CH, Alagjozovski H
    Editorial to: Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024;412:132299.
    PubMed    


  202. BONANNI M, Russo G, De Siati M, Tomao F, et al
    Holographic mixed reality for planning transcatheter aortic valve replacement.
    Int J Cardiol. 2024 Jul 2:132330. doi: 10.1016/j.ijcard.2024.132330.
    PubMed     Abstract available


  203. TIRADO-CONTE G, Pardo Sanz A, Salido Tahoces L
    Ascending aortic dilatation in TAVI: Actor or bystander?
    Int J Cardiol. 2024;406:132089.
    PubMed    


    June 2024
  204. RUSSO G, Hahn RT, Alessandrini H, Andreas M, et al
    Effects of tricuspid transcatheter edge-to-edge repair on tricuspid annulus diameter - Data from the TriValve registry.
    Int J Cardiol. 2024;405:131934.
    PubMed     Abstract available


  205. LV J, Wu Y, Xu H
    Transcatheter mitral valve intervention in patients with cancer: More efforts are needed.
    Int J Cardiol. 2024 Jun 15:132271. doi: 10.1016/j.ijcard.2024.132271.
    PubMed    


  206. HOLLOWELL M, Banno J, Marsy D, Shrestha N, et al
    Ventricular late gadolinium enhancement by cardiac MRI as a predictor of atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2024 Jun 13:132263. doi: 10.1016/j.ijcard.2024.132263.
    PubMed     Abstract available


  207. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Valve-in-valve after transcatheter aortic valve embolization: Do we need to align the commissures?
    Int J Cardiol. 2024 Jun 11:132255. doi: 10.1016/j.ijcard.2024.132255.
    PubMed    


  208. D'AMARIO D, Laborante R, Mennuni M, Adamo M, et al
    Efficacy and safety of trans-catheter repair devices for mitral regurgitation: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jun 6:132245. doi: 10.1016/j.ijcard.2024.132245.
    PubMed     Abstract available


  209. AYYAD M, Jabri A, Khalefa BB, Al-Abdouh A, et al
    Efficacy and safety of TAVR versus SAVR in patients with small aortic annuli: A systematic review and meta-analysis.
    Int J Cardiol. 2024 Jun 6:132243. doi: 10.1016/j.ijcard.2024.132243.
    PubMed     Abstract available


  210. KIRCHNER J, Gercek M, Gesch J, Omran H, et al
    Artificial intelligence-analyzed computed tomography in patients undergoing transcatheter tricuspid valve repair.
    Int J Cardiol. 2024 Jun 5:132233. doi: 10.1016/j.ijcard.2024.132233.
    PubMed     Abstract available


  211. SUNAGA A, Matsuoka Y, Nakatani D, Okada K, et al
    Extensive ablation for persistent atrial fibrillation patients with mitral regurgitation: Insights from the EARNEST-PVI prospective randomized trial.
    Int J Cardiol. 2024 Jun 3:132231. doi: 10.1016/j.ijcard.2024.132231.
    PubMed     Abstract available


  212. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
    Response to: Regard to assessing agreement between two raters with kappa statistics.
    Int J Cardiol. 2024;404:131978.
    PubMed    


  213. GESKE JB, Schaff HV
    Role of experience in myectomy for hypertrophic cardiomyopathy: With very high procedural volume, myectomy remains low-risk even with concomitant procedure need.
    Int J Cardiol. 2024;404:131961.
    PubMed    


  214. ANG SP, Chia JE
    Reevaluating female survival benefit in TAVR: A closer look in the current era.
    Int J Cardiol. 2024;404:131935.
    PubMed    


    May 2024
  215. SHI W, Feng D, Hu X, Wang C, et al
    Prediction of hypoattenuating leaflet thickening in patients underwent transcatheter aortic valves replacement based on clinical factors and 4D-computed tomography morphological characteristics: A retrospective cross-sectional study.
    Int J Cardiol. 2024 May 28:132219. doi: 10.1016/j.ijcard.2024.132219.
    PubMed     Abstract available


  216. AURIGEMMA C, Busco M, Bianchini F, Bianchini E, et al
    Clinical impact of multiple resheathing during transcatheter aortic valve implantation with Evolut self-expanding valves.
    Int J Cardiol. 2024 May 28:132218. doi: 10.1016/j.ijcard.2024.132218.
    PubMed     Abstract available


  217. WAZZAN AAL, Taconne M, Rolle VL, Forsaa MI, et al
    Risk profiles for ventricular arrhythmias in hypertrophic cardiomyopathy through clustering analysis including left ventricular strain.
    Int J Cardiol. 2024 May 24:132167. doi: 10.1016/j.ijcard.2024.132167.
    PubMed     Abstract available


  218. RELLA V, Maurizi N, Bernardini A, Brasca FM, et al
    Candidacy and long-term outcomes of subcutaneous implantable cardioverter-defibrillators in current practice in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2024 May 23:132202. doi: 10.1016/j.ijcard.2024.132202.
    PubMed     Abstract available


  219. MARTIN M, Rozado J
    Imaging in severe aortic stenosis: Looking at the future.
    Int J Cardiol. 2024 May 16:132183. doi: 10.1016/j.ijcard.2024.132183.
    PubMed    


  220. SEE C, Kim Y, Park J, Wang Y, et al
    High- versus low-gradient aortic stenosis: Is our evaluation limited by aorto-mitral angle on cardiovascular CT?
    Int J Cardiol. 2024 May 14:132174. doi: 10.1016/j.ijcard.2024.132174.
    PubMed     Abstract available


  221. MONDA E, Boccia A, Altobelli I, Mauriello A, et al
    Effect of beta-blockers and angiotensin receptor blockers in reducing the aortic growth rate in children with bicuspid aortic valve-related aortopathy.
    Int J Cardiol. 2024;408:132067.
    PubMed     Abstract available


  222. VOGES I, Hansen JH
    Critical aortic stenosis - The long-term burden.
    Int J Cardiol. 2024;408:132134.
    PubMed    


  223. ALPERI A, Pascual I, Moris C, Avanzas P, et al
    Neo 2 transcatheter heart valve system: Direct towards a minimalistic procedure.
    Int J Cardiol. 2024;402:131883.
    PubMed    


  224. VESELKA J
    Estimating the risk of sudden death in hypertrophic cardiomyopathy might be solved by artificial intelligence.
    Int J Cardiol. 2024;402:131842.
    PubMed    


  225. GARAGOLI F, Chiabrando JG, Seropian IM, Lombardi M, et al
    Stroke risk after transcatheter aortic valve replacement in patients with carotid stenosis: A systematic review and meta-analysis.
    Int J Cardiol. 2024 May 1:132085. doi: 10.1016/j.ijcard.2024.132085.
    PubMed     Abstract available


    April 2024
  226. QIU Y, Li M, Song X, Li Z, et al
    Predictive nomogram for 28-day mortality risk in mitral valve disorder patients in the intensive care unit: A comprehensive assessment from the MIMIC-III database.
    Int J Cardiol. 2024 Apr 25:132105. doi: 10.1016/j.ijcard.2024.132105.
    PubMed     Abstract available


  227. LEE CY, Tsai CM, Chiang KC, Huang CC, et al
    Prognostic value of left ventricular and left atrial strain imaging in moderate to severe aortic stenosis: Insights from an Asian population.
    Int J Cardiol. 2024 Apr 25:132103. doi: 10.1016/j.ijcard.2024.132103.
    PubMed     Abstract available


  228. CHEN B, Zhang Q
    The role of left ventricular global work index on the prediction of cardiovascular mortality after transcatheter aortic valve implantation.
    Int J Cardiol. 2024 Apr 23:132101. doi: 10.1016/j.ijcard.2024.132101.
    PubMed    


  229. MARMAGKIOLIS K, Monlezun DJ, Caballero J, Cilingiroglu M, et al
    Prevalence, mortality, cost, and disparities in transcatheter mitral valve repair and replacement in cancer patients: Artificial intelligence and propensity score national 5-year analysis of 7495 procedures.
    Int J Cardiol. 2024 Apr 23:132091. doi: 10.1016/j.ijcard.2024.132091.
    PubMed     Abstract available


  230. GUO Y, Li H, Huang B, Hou L, et al
    LncRNA HOTAIR ameliorates calcific aortic valve disease by sponging miR-29b.
    Int J Cardiol. 2024 Apr 23:132094. doi: 10.1016/j.ijcard.2024.132094.
    PubMed    


  231. GERHARDT P, Shehu N, Ferrari I, Hullebrandt M, et al
    Quantifying aortic valve regurgitation in patients with congenital aortic valve disease by 2D and 4D flow magnetic resonance analysis.
    Int J Cardiol. 2024 Apr 21:132084. doi: 10.1016/j.ijcard.2024.132084.
    PubMed     Abstract available


  232. DAHME T
    Effects of tricuspid edge-to-edge repair beyond leaflet approximation: Evidence for indirect tricuspid annuloplasty.
    Int J Cardiol. 2024;406:132066.
    PubMed    


  233. SADEGHIPOUR P, Mozafarybazargany M, Farrashi M, De Caterina R, et al
    Response to "Characteristics of the prothrombotic milieu in mitral stenosis patients managed with direct oral anticoagulants".
    Int J Cardiol. 2024 Apr 20:132076. doi: 10.1016/j.ijcard.2024.132076.
    PubMed    


  234. PRAKASH SK
    Editorial on Bellino et al., "Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe".
    Int J Cardiol. 2024 Apr 16:132047. doi: 10.1016/j.ijcard.2024.132047.
    PubMed    


  235. CHENG Y, Zhang Q
    Commentary on the mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2024 Apr 6:132033. doi: 10.1016/j.ijcard.2024.132033.
    PubMed    


  236. ALTIBI AM, Sapru A, Ghanem F, Zhao Y, et al
    Impact of concomitant surgical interventions on outcomes of septal myectomy in obstructive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;400:131790.
    PubMed     Abstract available


  237. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
    Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
    Int J Cardiol. 2024;400:131768.
    PubMed     Abstract available


    March 2024
  238. SANG SLW, Weissman C, Parker J, Timek T, et al
    Contemporary outcomes of surgical aortic valve replacement in patients referred for a transcatheter approach.
    Int J Cardiol. 2024 Mar 30:132004. doi: 10.1016/j.ijcard.2024.132004.
    PubMed     Abstract available


  239. BELLINO M, Antonini-Canterin F, Bossone E, Faggiano P, et al
    Aortopathy and aortic valve surgery in patients with bicuspid aortic valve with and without raphe.
    Int J Cardiol. 2024 Mar 30:132000. doi: 10.1016/j.ijcard.2024.132000.
    PubMed     Abstract available


  240. BLEIZIFFER S, Appleby C, Delgado V, Eltchaninoff H, et al
    Patterns of aortic valve replacement in Europe and adoption by sex.
    Int J Cardiol. 2024 Mar 28:131996. doi: 10.1016/j.ijcard.2024.131996.
    PubMed     Abstract available


  241. KALKAN S, Gursoy MO, Guner A, Kalcik M, et al
    Management of prosthetic valve thrombosis with unfractionated heparin.
    Int J Cardiol. 2024 Mar 19:131968. doi: 10.1016/j.ijcard.2024.131968.
    PubMed     Abstract available


  242. BICHUETTE LD, Lottenberg MP, Caramelli B
    Hypertrophic cardiomyopathy as a high-risk feature on perioperative care: How to deal with this self-fulfilling prophecy?
    Int J Cardiol. 2024;399:131683.
    PubMed    


  243. ZACH DK, Schwegel N, Santner V, Winkelbauer L, et al
    Low-grade systemic inflammation and left ventricular dysfunction in hypertensive compared to non-hypertensive hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;399:131661.
    PubMed     Abstract available


  244. NASCIMENTO BR, Nunes MCP, da Silva JLP, Steer A, et al
    Outcomes of latent rheumatic heart disease: External validation of a simplified score in patients with and without secondary prophylaxis.
    Int J Cardiol. 2024;399:131662.
    PubMed     Abstract available


  245. FENG D, Zhao J, Niu G, Zhang Y, et al
    Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.
    Int J Cardiol. 2024 Mar 11:131948. doi: 10.1016/j.ijcard.2024.131948.
    PubMed     Abstract available


  246. BONELLO B, Issitt R, Hughes M, Carr M, et al
    Long-term outcome after neonatal intervention for congenital critical aortic stenosis.
    Int J Cardiol. 2024 Mar 2:131932. doi: 10.1016/j.ijcard.2024.131932.
    PubMed     Abstract available


  247. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
    Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
    Int J Cardiol. 2024;398:131601.
    PubMed     Abstract available


  248. LIU Z, Wei P, Jiang H, Zhang F, et al
    Corrigendum to 'Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019' [Int. J. Cardiol. 395(2024) 131561].
    Int J Cardiol. 2024 Mar 1:131919. doi: 10.1016/j.ijcard.2024.131919.
    PubMed    


    February 2024
  249. BOURG C, Lee KC, Donal E
    Understanding myocardial mechanics in primary mitral regurgitation: A contemporary approach.
    Int J Cardiol. 2024 Feb 17:131882. doi: 10.1016/j.ijcard.2024.131882.
    PubMed    


  250. DI MAURO M, Guarracini S, Mazzocchetti L, Capuzzi D, et al
    Transcatheter bicaval valve system for the treatment of severe isolated tricuspid regurgitation. Features from a single-Centre experience.
    Int J Cardiol. 2024 Feb 16:131864. doi: 10.1016/j.ijcard.2024.131864.
    PubMed     Abstract available


  251. AKHTAR KH, Pahuja M, Baber U
    Self-expanding or balloon-expandable valve for TAVR in low risk patients: The jury is still out!
    Int J Cardiol. 2024;397:131619.
    PubMed    


  252. DE MARZO V, Zimarino M
    The value of transaxillary access for TAVI.
    Int J Cardiol. 2024;397:131448.
    PubMed    


  253. FATIMA K, Uddin QS, Tharwani ZH, Kashif MAB, et al
    Concomitant transthyretin cardiac amyloidosis in patients undergoing TAVR for aortic stenosis: A systemic review and meta-analysis.
    Int J Cardiol. 2024 Feb 15:131854. doi: 10.1016/j.ijcard.2024.131854.
    PubMed     Abstract available


  254. DANDEL M
    It is time to think about further optimization of the echocardiographic assessment of left ventricular responses to mitral regurgitation.
    Int J Cardiol. 2024 Feb 9:131841. doi: 10.1016/j.ijcard.2024.131841.
    PubMed    


  255. KWAK S, Lee HJ, Lee H, Park JB, et al
    Age-dependent association of metabolic dyslipidemia with clinical expression of hypertrophic cardiomyopathy.
    Int J Cardiol. 2024;396:131574.
    PubMed     Abstract available


    January 2024
  256. KURASAWA S, Imaizumi T, Kondo T, Hishida M, et al
    Relationship between peak aortic jet velocity and progression of aortic stenosis in patients undergoing hemodialysis.
    Int J Cardiol. 2024 Jan 30:131822. doi: 10.1016/j.ijcard.2024.131822.
    PubMed     Abstract available


  257. ELKOUMY A, Ruck A, Abdel-Wahab M, Thiele H, et al
    ACURATE neo2 Transcatheter aortic valve implantation without balloon aortic valvuloplasty - direct ACURATE neo2.
    Int J Cardiol. 2024 Jan 19:131792. doi: 10.1016/j.ijcard.2024.131792.
    PubMed     Abstract available


  258. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
    Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
    Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
    PubMed     Abstract available


  259. CARABETTA N, Siller-Matula JM, Boccuto F, Panuccio G, et al
    Commissural alignment during TAVR reduces the risk of overlap to coronary ostia.
    Int J Cardiol. 2024;395:131572.
    PubMed     Abstract available


  260. PARATZ ED, Stub D, Sutherland N, Gutman S, et al
    The challenge of risk stratification in hypertrophic cardiomyopathy: Clinical, genetic and imaging insights from a quaternary referral centre.
    Int J Cardiol. 2024;395:131416.
    PubMed     Abstract available


  261. DEL FRANCO A, Biagioni G, Mazzoni C, Cappelli F, et al
    Amyloidosis in spinal stenosis: How, when and whether cardiac screening has a clinical impact.
    Int J Cardiol. 2024;395:131413.
    PubMed    


  262. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
    Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
    Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
    PubMed     Abstract available


  263. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
    Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
    Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
    PubMed     Abstract available


  264. LERMAN TT, Levi A, Kornowski R
    Response to: "Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond".
    Int J Cardiol. 2024 Jan 5:131751. doi: 10.1016/j.ijcard.2024.131751.
    PubMed    


  265. VAN WELY M, van Nieuwkerk AC, Rooijakkers M, van der Wulp K, et al
    Transaxillary versus transfemoral access as default access in TAVI: A propensity matched analysis.
    Int J Cardiol. 2024;394:131353.
    PubMed     Abstract available


    December 2023
  266. MOSCARELLA E, Ielasi A, Montonati C, Pellegrini D, et al
    Comparing two-year outcomes of balloon-expandable Myval and self-expanding Evolut R in severe aortic valve stenosis.
    Int J Cardiol. 2023 Dec 31:131701. doi: 10.1016/j.ijcard.2023.131701.
    PubMed     Abstract available


  267. ANWER S, Nussbaum S, Winkler NE, Benz DC, et al
    Left ventricular global work index and prediction of cardiovascular mortality after transcatheter aortic valve implantation.
    Int J Cardiol. 2023 Dec 29:131660. doi: 10.1016/j.ijcard.2023.131660.
    PubMed     Abstract available


  268. HIRAM R
    The duration of atrial fibrillation might be associated with right heart disease severity.
    Int J Cardiol. 2023 Dec 28:131689. doi: 10.1016/j.ijcard.2023.131689.
    PubMed    


  269. ANTIA A, Pius R, Ndukauba C, Zarauz VR, et al
    Temporal trends in the utilization and outcome of transcatheter aortic valve replacement across racial and ethnic groups. A nationwide analysis.
    Int J Cardiol. 2023 Dec 22:131669. doi: 10.1016/j.ijcard.2023.131669.
    PubMed     Abstract available


  270. CAETANO L DA SILVA, Gibicoski TB, Rodriguez F, Scabello I, et al
    Impact of carotid artery stenosis on outcomes of transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Dec 22:131670. doi: 10.1016/j.ijcard.2023.131670.
    PubMed     Abstract available


  271. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
    Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
    Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
    PubMed     Abstract available


  272. IZUMI K, Utsunomiya H, Takeuchi M, Hamada A, et al
    Relationship between duration of atrial fibrillation and right heart structure remodeling as assessed by 3-dimensional transesophageal echocardiography.
    Int J Cardiol. 2023 Dec 21:131667. doi: 10.1016/j.ijcard.2023.131667.
    PubMed     Abstract available


  273. BOLETI OD, Roussos S, Norrish G, Field E, et al
    Sudden cardiac death in childhood RASopathy-associated hypertrophic cardiomyopathy: Validation of the HCM risk-kids model and predictors of events.
    Int J Cardiol. 2023;393:131405.
    PubMed     Abstract available


  274. MORONI A, Tondi L, Milani V, Pieroni M, et al
    Left atrial remodeling in hypertrophic cardiomyopathy and Fabry disease: A CMR-based head-to-head comparison and outcome analysis.
    Int J Cardiol. 2023;393:131357.
    PubMed     Abstract available


  275. OZLEK B
    Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
    Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
    PubMed    


  276. GOZDEK M, Kowalewski M
    Evolut R and Evolut PRO vs. Sapien 3 for transcatheter aortic valve implantation - The 'generation gap' and beyond.
    Int J Cardiol. 2023 Dec 8:131647. doi: 10.1016/j.ijcard.2023.131647.
    PubMed    


  277. SEE C, Wang Y, Yang Y, Tirziu D, et al
    Impact of sex on transcatheter aortic valve replacement outcomes: Results of a single-center study.
    Int J Cardiol. 2023 Dec 6:131643. doi: 10.1016/j.ijcard.2023.131643.
    PubMed     Abstract available


  278. HOLIEROOK M, Henstra MJ, Dolman DJ, Chekanova EV, et al
    Higher Edmonton Frail Scale prior to transcatheter Aortic Valve Implantation is related to longer hospital stay and mortality.
    Int J Cardiol. 2023 Dec 6:131637. doi: 10.1016/j.ijcard.2023.131637.
    PubMed     Abstract available


  279. MATTIG I, Steudel T, Barzen G, Frumkin D, et al
    Diagnostic value of papillary muscle hypertrophy and mitral valve thickness to discriminate cardiac amyloidosis and Fabry disease.
    Int J Cardiol. 2023 Dec 3:131629. doi: 10.1016/j.ijcard.2023.131629.
    PubMed     Abstract available


  280. DORIAN D, Scolari FL, Habib M, Brahmbhatt DH, et al
    Association of duration and intensity of exercise with phenotypic expression in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;392:131253.
    PubMed     Abstract available


    November 2023
  281. FERNANDEZ-GOLFIN C, Gonznalez-Gomez A
    Unmasking tricuspid regurgitation.
    Int J Cardiol. 2023 Nov 28:131609. doi: 10.1016/j.ijcard.2023.131609.
    PubMed    


  282. KIKUCHI S, Minamimoto Y, Matsushita K, Cho T, et al
    Ratio of left ventricular outflow tract area to aortic annulus area and complete atrioventricular block after transcatheter aortic valve replacement for aortic stenosis.
    Int J Cardiol. 2023 Nov 27:131608. doi: 10.1016/j.ijcard.2023.131608.
    PubMed     Abstract available


  283. CHAN J, Narayan P, Fudulu DP, Dong T, et al
    Trend in mitral valve prostheses of choice and early outcomes in the United Kingdom.
    Int J Cardiol. 2023 Nov 25:131607. doi: 10.1016/j.ijcard.2023.131607.
    PubMed     Abstract available


  284. HAUGE SW, Estensen ME, Persson R, Abebe S, et al
    The importance of concomitant mitral regurgitation for estimates of mitral valve area by pressure half time in patients with chronic rheumatic heart disease.
    Int J Cardiol. 2023 Nov 21:131600. doi: 10.1016/j.ijcard.2023.131600.
    PubMed     Abstract available


  285. MOSCARELLI M, Sollami G, Lentini E, Prestera R, et al
    About different localization of hypoattenuated lesions following transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Nov 16:131597. doi: 10.1016/j.ijcard.2023.131597.
    PubMed     Abstract available


  286. HU D, Lan T, Chen Y, Chen L, et al
    An 18-year evolution of congenital heart disease in China: An echocardiographic database-based study.
    Int J Cardiol. 2023;391:131286.
    PubMed     Abstract available


  287. KHOURY S, Bhatia RT, Marwaha S, Miles C, et al
    Ethnic and sex-related differences at presentation in apical hypertrophic cardiomyopathy: An observational cross-sectional study.
    Int J Cardiol. 2023;391:131265.
    PubMed     Abstract available


  288. WU Z, Nie C, Zhu C, Meng Y, et al
    Mitral annular calcification in obstructive hypertrophic cardiomyopathy: Incidence, risk factors, and prognostic value after myectomy.
    Int J Cardiol. 2023;391:131266.
    PubMed     Abstract available


  289. DE SARRO R, Sabatino J
    Left atrial function's evaluation in aortic stenosis: A clinical imperative.
    Int J Cardiol. 2023 Nov 11:131579. doi: 10.1016/j.ijcard.2023.131579.
    PubMed    


  290. LOSI MA, Monda E, Lombardi R, Lioncino M, et al
    Prediction of incident atrial fibrillation in hypertrophic cardiomyopathy.
    Int J Cardiol. 2023 Nov 9:131575. doi: 10.1016/j.ijcard.2023.131575.
    PubMed     Abstract available


  291. ZHOU N, Liu A, Weng H, Liu W, et al
    Three-dimensional echocardiography reveals early mitral valve alterations in hypertrophic cardiomyopathy genetic mutation carriers.
    Int J Cardiol. 2023 Nov 8:131576. doi: 10.1016/j.ijcard.2023.131576.
    PubMed     Abstract available


  292. DORES H, Toste A, Cardim N
    Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
    Int J Cardiol. 2023;390:131260.
    PubMed     Abstract available


  293. SALA A, Alfieri O
    Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
    Int J Cardiol. 2023;390:131146.
    PubMed    


  294. NEMES A
    Three-dimensional echocardiography for Tricuspid Annulus - Transthoracic or transoesophageal approach?
    Int J Cardiol. 2023;390:131170.
    PubMed    


    October 2023
  295. BRANDES A
    Rheumatic mitral valve stenosis and atrial fibrillation - Vicious twins.
    Int J Cardiol. 2023 Oct 30:131566. doi: 10.1016/j.ijcard.2023.131566.
    PubMed    


  296. LIU Z, Wei P, Jiang H, Zhang F, et al
    Alerting trends in epidemiology for non-rheumatic degenerative mitral valve disease, 1990-2019: An age-period-cohort analysis for the Global Burden of Disease Study 2019.
    Int J Cardiol. 2023 Oct 30:131561. doi: 10.1016/j.ijcard.2023.131561.
    PubMed     Abstract available


  297. MOSCARELLI M, Prestera R, Fiore C, Pernice V, et al
    Evaluation of the anatomic sinus after transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Oct 20:131551. doi: 10.1016/j.ijcard.2023.131551.
    PubMed     Abstract available


  298. HOU Q, Wu W, Fang L, Zhang X, et al
    Patient-specific computational fluid dynamics for hypertrophic obstructive cardiomyopathy.
    Int J Cardiol. 2023;389:131263.
    PubMed     Abstract available


  299. BADWAN O, Mirzai S, Skoza W, Hawk F, et al
    Clinical outcomes following tricuspid transcatheter edge-to-edge repair with PASCAL: A meta-analysis.
    Int J Cardiol. 2023;389:131194.
    PubMed     Abstract available


  300. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
    Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
    Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
    PubMed     Abstract available


  301. BHOGAL S, Waksman R, Shea C, Zhang C, et al
    Self-expanding and balloon-expandable valves in low risk TAVR patients.
    Int J Cardiol. 2023 Oct 12:131431. doi: 10.1016/j.ijcard.2023.131431.
    PubMed     Abstract available


  302. MYAGMARDORJ R, Stassen J, Nabeta T, Hirasawa K, et al
    Impact of chronic obstructive pulmonary disease on right ventricular function and remodeling after aortic valve replacement.
    Int J Cardiol. 2023 Oct 5:131414. doi: 10.1016/j.ijcard.2023.131414.
    PubMed     Abstract available


  303. CHEN X
    The real world of stroke incidence in patients with hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;388:131172.
    PubMed    


  304. MARTIN M, Moris C
    Subclinical leaflet thrombosis after TAVI: To be or not to be.
    Int J Cardiol. 2023;388:131140.
    PubMed    


    September 2023
  305. YAMANO M, Yamano T, Nakamura T, Zukeran T, et al
    Mitral regurgitation outcomes after transcatheter atrial septal defect closure.
    Int J Cardiol. 2023 Sep 28:131404. doi: 10.1016/j.ijcard.2023.131404.
    PubMed     Abstract available


  306. WINKLER NE, Anwer S, Rumpf PM, Tsiourantani G, et al
    Left atrial pump strain predicts long-term survival after transcatheter aortic valve implantation.
    Int J Cardiol. 2023 Sep 28:131403. doi: 10.1016/j.ijcard.2023.131403.
    PubMed     Abstract available


  307. CHANG WT, Lin CH, Lee WC, Kan WC, et al
    Signal intensity coefficient as a detector of aortic stenosis-induced myocardial fibrosis and its correlation to the long term outcome.
    Int J Cardiol. 2023 Sep 17:131367. doi: 10.1016/j.ijcard.2023.131367.
    PubMed     Abstract available


  308. KHARBANDA RK, Ramdat Misier NL, Van den Eynde J, El Mathari S, et al
    Outcomes of concomitant surgical ablation in patients undergoing surgical myectomy for hypertrophic obstructive cardiomyopathy: A systematic review and meta-analysis.
    Int J Cardiol. 2023;387:131099.
    PubMed     Abstract available


  309. SOARES JR, Carvalho VT, Lodi-Junqueira L, Fonseca IMG, et al
    Assessment of the left atrial volume and function following percutaneous mitral balloon valvuloplasty: Insights into acute and late impact of atrial fibrillation on atrial remodeling.
    Int J Cardiol. 2023 Sep 12:131361. doi: 10.1016/j.ijcard.2023.131361.
    PubMed     Abstract available


  310. LEOW R, Kong WKF, Li TY, Poh KK, et al
    Yeo's index: A novel index that combines anatomic and haemodynamic assessment of the severity of mitral stenosis.
    Int J Cardiol. 2023 Sep 7:131350. doi: 10.1016/j.ijcard.2023.131350.
    PubMed     Abstract available


  311. HASEGAWA H, Kuwajima K, Kagawa S, Yamane T, et al
    Impact of eccentric jet on outcomes in patients with atrial functional mitral regurgitation: An echocardiographic study.
    Int J Cardiol. 2023 Sep 5:131342. doi: 10.1016/j.ijcard.2023.131342.
    PubMed     Abstract available


  312. YAMAZAKI C, Higuchi R, Saji M, Takamisawa I, et al
    Discrepancy between invasive and echocardiographic transvalvular gradient after TAVI: Insights from the LAPLACE-TAVI registry.
    Int J Cardiol. 2023;386:17-23.
    PubMed     Abstract available


    August 2023
  313. GENTILE F, Buoncristiani F, Sciarrone P, Bazan L, et al
    Left ventricular outflow tract velocity-time integral improves outcome prediction in patients with secondary mitral regurgitation.
    Int J Cardiol. 2023 Aug 19:131272. doi: 10.1016/j.ijcard.2023.131272.
    PubMed     Abstract available


  314. LI S, Fang L, Wu W, Zhang Z, et al
    Echocardiographic diagnosis of rupture of mitral valve papillary muscle.
    Int J Cardiol. 2023 Aug 18:131273. doi: 10.1016/j.ijcard.2023.131273.
    PubMed     Abstract available


  315. PIERONI M, Ciabatti M, Bolognese L
    Stroke in hypertrophic cardiomyopathy. Never mind the rhythm.
    Int J Cardiol. 2023;385:41-42.
    PubMed    


  316. NEMES A
    The tricuspid annulus in repaired tetralogy of Fallot - what does it play and what does it not?
    Int J Cardiol. 2023;385:22.
    PubMed    


    July 2023
  317. SISINNI A, Estevez-Loureiro R
    The K-clip: Time for a new tricuspid valve focal annuloplasty system.
    Int J Cardiol. 2023 Jul 31:131234. doi: 10.1016/j.ijcard.2023.131234.
    PubMed    


  318. BARKI M, Ielasi A, Buono A, Maffeo D, et al
    Transcatheter aortic valve replacement with the self-expanding ACURATE Neo2 in patients with horizontal aorta: Insights from the ITAL-neo registry.
    Int J Cardiol. 2023 Jul 31:131236. doi: 10.1016/j.ijcard.2023.131236.
    PubMed     Abstract available


  319. SANCHIS L, Farrero M
    Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
    Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
    PubMed    


  320. MIRZAI S, Aleixo GFP, Mazumder S, Berglund F, et al
    Sarcopenia evaluation on cardiac magnetic resonance imaging in older adults for outcomes prediction following surgical aortic valve replacement.
    Int J Cardiol. 2023 Jul 25:131216. doi: 10.1016/j.ijcard.2023.131216.
    PubMed     Abstract available


  321. BHOGAL S, Rogers T, Merdler I, Reddy P, et al
    Evolut PRO/PRO+ versus Evolut R system for transcatheter aortic valve replacement.
    Int J Cardiol. 2023 Jul 19:131196. doi: 10.1016/j.ijcard.2023.131196.
    PubMed     Abstract available


  322. ZHANG X, Jin Q, Pan W, Li W, et al
    First-in-human study of the K-Clip transcatheter annular repair system for severe functional tricuspid regurgitation.
    Int J Cardiol. 2023 Jul 11:131174. doi: 10.1016/j.ijcard.2023.131174.
    PubMed     Abstract available


  323. CHATTERJEE A, Kazui T, Acharya D
    Growing prevalence of aortic stenosis - Question of age or better recognition?
    Int J Cardiol. 2023 Jul 8:131155. doi: 10.1016/j.ijcard.2023.131155.
    PubMed    


  324. XU Z, Dai XF, Lin F, Chen LW, et al
    Two-incision totally thoracoscopic mitral valve repair combined with radiofrequency atrial fibrillation ablation in rheumatic mitral valve disease: Early results of a case series of 43 consecutive patients.
    Int J Cardiol. 2023 Jul 8:131158. doi: 10.1016/j.ijcard.2023.131158.
    PubMed     Abstract available


  325. MASSERA D, Sherrid MV, Maron MS, Rowin EJ, et al
    How common is hypertrophic cardiomyopathy... really?: Disease prevalence revisited 27 years after CARDIA.
    Int J Cardiol. 2023;382:64-67.
    PubMed     Abstract available


  326. SA MP, Tasoudis P, Jacquemyn X, Van den Eynde J, et al
    Long-term outcomes of valve-sparing root versus composite valve graft replacement for acute type A aortic dissection: Meta-analysis of reconstructed time-to-event data.
    Int J Cardiol. 2023;382:12-19.
    PubMed     Abstract available


    June 2023
  327. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
    The long-term clinical course of moderate tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
    PubMed     Abstract available


  328. LIND A, Esfahan MA, Totzeck M, Al-Rashid F, et al
    Virtual reality-assisted distraction during transcatheter aortic valve implantation under local anaesthesia: A randomised study.
    Int J Cardiol. 2023 Jun 22:131130. doi: 10.1016/j.ijcard.2023.131130.
    PubMed     Abstract available


  329. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
    2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
    Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
    PubMed     Abstract available


  330. LEE M, Shechter A, Han D, Nguyen LC, et al
    Left ventricular morphologic progression in apical hypertrophic cardiomyopathy.
    Int J Cardiol. 2023;381:62-69.
    PubMed     Abstract available


  331. BOURG C, Curtis E, Donal E
    Navigating upstream and downstream: Unleashing the prognostic potential of RVFWLS/PASP ratio in severe tricuspid regurgitation.
    Int J Cardiol. 2023 Jun 12:S0167-5273(23)00881.
    PubMed    


  332. RAHIMI M, Kpodonu J
    Myectomy or myomectomy, that is the question.
    Int J Cardiol. 2023;380:28.
    PubMed    


  333. SCHEFFERS LE, Kok R, van den Berg LE, van den Hout JMP, et al
    Effects of enzyme replacement therapy on cardiac function in classic infantile Pompe disease.
    Int J Cardiol. 2023;380:65-71.
    PubMed     Abstract available


    May 2023
  334. FERSTL P, Achenbach S, Marwan M, Bittner DO, et al
    Comparison of oral anticoagulation by vitamin-K antagonists and non-vitamin-K antagonists for treatment of leaflet thickening after transcatheter aortic valve implantation (TAVI).
    Int J Cardiol. 2023 May 25:S0167-5273(23)00727.
    PubMed     Abstract available


  335. ZHOU Y, Lin X, Zhu Q, Li H, et al
    Association between trajectories in cardiac damage and clinical outcomes after transcatheter aortic valve replacement.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00707.
    PubMed     Abstract available


  336. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
    Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
    PubMed     Abstract available


  337. EGBE AC, Miranda WR, Anderson JH, Pellikka PA, et al
    Left ventricular adaptation to aortic regurgitation in adults with repaired coarctation of aorta.
    Int J Cardiol. 2023 May 4:S0167-5273(23)00650.
    PubMed     Abstract available


    April 2023
  338. AMBROSY AP, Go AS, Leong TK, Garcia EA, et al
    Temporal trends in the prevalence and severity of aortic stenosis within a contemporary and diverse community-based cohort.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00601.
    PubMed     Abstract available


  339. SHOJI S, Kuno T, Malik A, Briasoulis A, et al
    Association between institutional volume of transcatheter mitral valve repair and readmission rates: A report from the National Readmission Database.
    Int J Cardiol. 2023 Apr 19:S0167-5273(23)00588.
    PubMed     Abstract available


  340. FUMAGALLI C, Bonanni F, Beltrami M, Ruggieri R, et al
    Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring.
    Int J Cardiol. 2023 Apr 13:S0167-5273(23)00523.
    PubMed     Abstract available


  341. LEIBOWITZ D, Yoshida Y, Jin Z, Nakanishi K, et al
    Factors associated with the progression of aortic valve calcification in older adults.
    Int J Cardiol. 2023 Apr 6:S0167-5273(23)00470.
    PubMed     Abstract available


  342. ELKOUMY A, Jose J, Gunasekaran S, Kumar A, et al
    Angiographic quantification of aortic regurgitation following myval octacor implantation; independent core lab adjudication.
    Int J Cardiol. 2023 Apr 5:S0167-5273(23)00516.
    PubMed     Abstract available


  343. MERLO M, Folgheraiter A, Sinagra G
    Evolving mortality and clinical scenarios in HCM: Where are we?
    Int J Cardiol. 2023;376:97-99.
    PubMed    


    March 2023
  344. MENG H, Zhao X, Wang JD, Wan LY, et al
    Comparison between multimodality imaging approaches for measurement of the tricuspid annulus in severe tricuspid regurgitation.
    Int J Cardiol. 2023 Mar 31:S0167-5273(23)00434.
    PubMed     Abstract available


  345. DE MARZO V, Viglino U, Zecchino S, Matos JG, et al
    Supra-renal aortic atheroma extent and composition predict acute kidney injury after transcatheter aortic valve replacement: A three-dimensional computed tomography study.
    Int J Cardiol. 2023 Mar 29:S0167-5273(23)00464.
    PubMed     Abstract available


  346. MENDEL B, Kohar K, Amirah S, Vidya AP, et al
    The outcomes of fetal aortic valvuloplasty in critical aortic stenosis: A systematic review and meta-analysis.
    Int J Cardiol. 2023 Mar 28:S0167-5273(23)00461.
    PubMed     Abstract available


  347. ESPOSITO G, Montalto C, Crimi G, Grippo R, et al
    Time course of ischemic and bleeding burden in consecutive patients undergoing transcatheter aortic valve replacement (FOCUS-ONE registry).
    Int J Cardiol. 2023 Mar 8:S0167-5273(23)00336.
    PubMed     Abstract available


    February 2023
  348. LEONE PP, Gohar A, Pagnesi M, Mangieri A, et al
    Clinical outcomes in women and men with small aortic annuli undergoing transcatheter aortic valve implantation: A multicenter, retrospective, propensity score-matched comparison.
    Int J Cardiol. 2023 Feb 28:S0167-5273(23)00270.
    PubMed     Abstract available


  349. MALTES S, Abecasis J, Santos RR, Lopes P, et al
    LGE prevalence and patterns in severe aortic stenosis: When "junctional" means the same.
    Int J Cardiol. 2023 Feb 22:S0167-5273(23)00250.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Valvular Heart Disease is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum